Local Therapy for Isolated Central Nervous System Progression Among Patients Receiving Antibody-Drug Conjugate Therapy

Local Therapy for Isolated Central Nervous System Progression Among Patients Receiving Antibody-Drug Conjugate Therapy

Purpose: Antibody drug conjugates (ADCs) are an increasingly important class of therapeutics among patients with breast, lung, urothelial, and other malignancies. Guidelines recommend local therapy and continuation of current systemic therapy among patients with isolated brain relapse. We describe t...

Full description

Saved in:
Bibliographic Details
Main Authors: Emily S. Lebow, MD, Jordan Eichholz, MS, Zhigang Zhang, PhD, Nicolas Toumbacaris, MSPH, Brandon Imber, MD, MA, Linda Chen, MD, Quincey LaPlant, MD, PhD, Josh Yamada, MD, Luke R.G. Pike, MD, DPhil, Shanu Modi, MD, Andrew D. Seidman, MD, Kathryn Beal, MD, Nelson S. Moss, MD, Yao Yu, MD
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109425000028
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items